MXPA03004577A - Analisis de expresion de acidos nucleicos y polipeptidos del inhibidor de diferenciacion utiles en diagnostico y tratamiento de cancer de prostata. - Google Patents

Analisis de expresion de acidos nucleicos y polipeptidos del inhibidor de diferenciacion utiles en diagnostico y tratamiento de cancer de prostata.

Info

Publication number
MXPA03004577A
MXPA03004577A MXPA03004577A MXPA03004577A MXPA03004577A MX PA03004577 A MXPA03004577 A MX PA03004577A MX PA03004577 A MXPA03004577 A MX PA03004577A MX PA03004577 A MXPA03004577 A MX PA03004577A MX PA03004577 A MXPA03004577 A MX PA03004577A
Authority
MX
Mexico
Prior art keywords
diagnosis
inhibitor
treatment
nucleic acids
prostate cancer
Prior art date
Application number
MXPA03004577A
Other languages
English (en)
Inventor
Kimberly A Gillis
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of MXPA03004577A publication Critical patent/MXPA03004577A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MXPA03004577A 2000-11-28 2001-11-28 Analisis de expresion de acidos nucleicos y polipeptidos del inhibidor de diferenciacion utiles en diagnostico y tratamiento de cancer de prostata. MXPA03004577A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25337400P 2000-11-28 2000-11-28
PCT/US2001/044495 WO2002044417A2 (en) 2000-11-28 2001-11-28 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer

Publications (1)

Publication Number Publication Date
MXPA03004577A true MXPA03004577A (es) 2003-09-04

Family

ID=22959998

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004577A MXPA03004577A (es) 2000-11-28 2001-11-28 Analisis de expresion de acidos nucleicos y polipeptidos del inhibidor de diferenciacion utiles en diagnostico y tratamiento de cancer de prostata.

Country Status (14)

Country Link
US (1) US20020182614A1 (es)
EP (1) EP1356107A2 (es)
JP (1) JP2004526424A (es)
AU (1) AU2002239363A1 (es)
BR (1) BR0115689A (es)
CA (1) CA2429721A1 (es)
HU (1) HUP0303890A3 (es)
IL (1) IL155953A0 (es)
MX (1) MXPA03004577A (es)
NO (1) NO20032393L (es)
NZ (1) NZ526706A (es)
PL (1) PL365794A1 (es)
WO (1) WO2002044417A2 (es)
ZA (1) ZA200304997B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001290949A1 (en) * 2000-09-14 2002-03-26 California Pacific Medical Center Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
CA2505416A1 (en) * 2002-11-21 2004-06-10 Wyeth Methods for diagnosing rcc and other solid tumors
US7643943B2 (en) 2003-02-11 2010-01-05 Wyeth Llc Methods for monitoring drug activities in vivo
US20060194211A1 (en) * 2003-04-29 2006-08-31 Burczynski Michael E Methods for prognosis and treatment of solid tumors
BRPI0413334A (pt) * 2003-09-05 2006-10-10 Sanofi Pasteur Ltd vetores de multiantìgenos para melanoma
CA2644330C (en) 2006-03-24 2012-05-01 Phenomenome Discoveries Inc. Biomarkers useful for diagnosing prostate cancer, and methods thereof
US20240142456A1 (en) * 2021-03-08 2024-05-02 Acurasysbio Co., Ltd. Composition for diagnosing pancreatic cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997005283A1 (en) * 1995-08-01 1997-02-13 Sloan-Kettering Institute For Cancer Research Id AS A DIAGNOSTIC MARKER IN TUMOR CELLS
AU2024799A (en) * 1998-01-09 1999-07-26 President And Fellows Of Harvard College Immortalization of primary human keratinocytes by the helix-loop-helix protein, id-1
WO1999037811A1 (en) * 1998-01-21 1999-07-29 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
AU2001290949A1 (en) * 2000-09-14 2002-03-26 California Pacific Medical Center Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma

Also Published As

Publication number Publication date
WO2002044417A9 (en) 2003-11-20
US20020182614A1 (en) 2002-12-05
PL365794A1 (en) 2005-01-10
WO2002044417A3 (en) 2003-07-24
ZA200304997B (en) 2004-09-27
EP1356107A2 (en) 2003-10-29
HUP0303890A2 (hu) 2004-03-01
HUP0303890A3 (en) 2006-03-28
IL155953A0 (en) 2003-12-23
JP2004526424A (ja) 2004-09-02
NZ526706A (en) 2005-03-24
CA2429721A1 (en) 2002-06-06
BR0115689A (pt) 2004-02-10
NO20032393L (no) 2003-07-03
AU2002239363A1 (en) 2002-06-11
NO20032393D0 (no) 2003-05-27
WO2002044417A2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
MXPA03004688A (es) Analisis de expresion de acidos nucleicos y polipeptidos fkbp utiles en diagnostico.
AU2002318112B2 (en) Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
HUP0203968A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
HK1152714A1 (en) Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer steap-1
EP1319178A4 (en) METHOD FOR IDENTIFYING CANCER MARKERS AND USES THEREOF FOR DIAGNOSING CANCER
EP1537140A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN 161P2F10B USEFUL IN THE TREATMENT AND DETECTION OF CANCER
AU6502199A (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
EP1517606A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN CURED 193P1E1B USEFUL IN THE TREATMENT AND DETECTION OF CANCER
AU2002256461A8 (en) Polypeptides and nucleic acids associated with cancer
EP1372719A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN WITH THE NAME 125P5C8 FOR THE TREATMENT AND DETECTION OF CANCER
PT1537140E (pt) Ácido nucleico e proteína correspondente designada 161p2f10b úteis no tratamento e detecção de cancro
MXPA03004577A (es) Analisis de expresion de acidos nucleicos y polipeptidos del inhibidor de diferenciacion utiles en diagnostico y tratamiento de cancer de prostata.
MXPA03004637A (es) Analisis de expresion de acidos nucleicos y polipeptidos kiaa utiles en diagnostico y tratamiento de cancer de prostata.
EP1573023A4 (en) NUCLEIC ACID AND CORRESPONDING PROTEIN NAMES 162P1E6 USEFUL IN THE DETECTION AND TREATMENT OF CANCER
MXPA03004579A (es) Analisis de expresion de acidos nucleicos del regulador de cromatina dependiente de actina y polipeptidos utiles en diagnostico y tratamiento del cancer de prostata.
GB0006408D0 (en) Expression of DNA or proteins in C. Elegans
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
EP1023076A4 (en) USE OF THE P-TEN TUMOR SUPPRESSOR GENE IN THE DIAGNOSIS AND TREATMENT OF CANCER
AU2001286541A1 (en) Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer
ZA200301143B (en) Biological materials and methods useful in the diagnosis and treatment of diseases.
GB9917491D0 (en) Biological materials and methods useful in the diagnosis and treastment of diseases
GB0128183D0 (en) Nucleic acid polypeptides and uses including diagnosis and treatment of ErbB2-related cancer
GB9906217D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB9917878D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases
GB0113011D0 (en) Biological materials and methods useful in the diagnosis and treatment of diseases